Clinical trials rarely fail because of science. They often fail due to unrealistic feasibility assumptions. Overestimated recruitment, underperforming sites, delayed activation, and amendments that drain budgets are common pitfalls. Every month lost is a month of lost patent lifetime. The Real Risk: Poor Site Selection Sponsors and CROs still rely heavily on: Historical relationships Email-based feasibility surveys Self-reported recruitment optimism Fragmented spreadsheets Th